SCHEDULE 13G/A: Nantahala Capital Boosts InspireMD Stake to 5.68%

Nantahala Capital Partners Limited Partnership has reported a 5.6761% beneficial ownership stake in InspireMD, Inc., including shares acquirable via warrants.

Summary

• Nantahala Capital Partners Limited Partnership (Nantahala) beneficially owns 2,418,016 shares of InspireMD, Inc. Common Stock.
• This ownership represents 5.6761% of InspireMD, Inc.'s total outstanding shares.
• The calculation is based on 41,720,662 shares outstanding, as reported in InspireMD's Form 10-Q filed on August 4, 2025.
• The beneficially owned shares include 879,245 shares that Nantahala may acquire within sixty days through the exercise of warrants.
• Nantahala holds shared voting power and shared dispositive power over all 2,418,016 shares.
• The securities were not acquired or held for the purpose of changing or influencing control of InspireMD, Inc., other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 7

Explanation: The filing indicates a significant beneficial ownership stake by an institutional investor, Nantahala Capital Partners, in InspireMD, Inc. This often signals a vote of confidence from a sophisticated investor, especially with the inclusion of exercisable warrants, which could lead to an increased stake. This is generally viewed positively by the market.

Positives

• An institutional investor, Nantahala Capital Partners, has disclosed a significant beneficial ownership stake of 5.6761% in InspireMD, Inc., signaling potential confidence in the company.
• The stake includes 879,245 shares acquirable through warrants, indicating a potential for increased investment.

Future Outlook

NA

Industry Context

The disclosure of a significant institutional stake by Nantahala Capital Partners in InspireMD, Inc., a company likely operating in the medical device or healthcare sector (given its name), suggests that institutional investors are identifying opportunities within this industry. Such investments can be a bellwether for sector-specific interest or perceived value.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders may view the significant institutional investment as a positive signal, potentially increasing confidence in the company's future prospects and attracting further investor interest.

Key Dates

Recommendation

The disclosure of a 5.6761% beneficial ownership stake by Nantahala Capital Partners, a known institutional investor, including shares acquirable through warrants, is a strong signal of institutional confidence in InspireMD, Inc. For a seasoned investor, this indicates that a sophisticated entity sees value in the company, potentially warranting a 'buy' recommendation to align with or capitalize on this institutional interest. While this filing alone doesn't provide fundamental financial data, the institutional backing is a significant qualitative factor.

Keywords

InspireMD, Nantahala Capital Partners, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investment, Warrants, Medical Devices, Healthcare